AzTrials
AzTrials

Inspiratory Strength Training (IST)REHAB-MVNCT07427121

Rehab and Mechanical Ventilation

A study testing Spinal cord stimulation and Inspiratory Strength Training in people with Inspiratory Strength Training (IST) and Transcutaneous Spinal Stimulation, run by University of Florida at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this research study is to evaluate the effects of a single session of rehabilitation in healthy adults, before noninvasive mechanical ventilation (MV). MV can help support breathing function during sleep or illness. Read more about this study

Who is it for?
Ages 25 to 80 yearsHealthy volunteers can take part
What is being tested?
Spinal cord stimulation and Inspiratory Strength Training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
16 participants
Where
1 siteUnited States
Study dates
30 Mar 2026to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Non-smokers Sedentary or recreationally active Normal lung function No history of claustrophobia

Who cannot join

  • Current smoking or vaping Obstructive lung disease Use of antibiotics or systemic corticosteroids to treat an acute condition History of sepsis or metastatic disease Post infectious conditions that affect breathing Diagnosed with a neurological or neuromuscular condition Any use of supplemental oxygen, continuous positive airway pressure (CPAP), or other positive pressure ventilation to treat sleep apnea Cardiac disease Orthopedic conditions that impair lung expansion Pregnancy Implanted metallic devices within 10 cm of the cervical spine

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Barbara K Smith, PhD, PT contact

352-294-5315

bksmith@ufl.edu

Ushna Khan, MD contact

352-273-6855

ushnakhan@ufl.edu

United States1 site, 1 recruiting
  • University of Florida

    Gainesville, Florida, 32610

    Barbara K. Smith, PhD, 352-294-5315, bksmith@phhp.ufl.edu

    Ushna Khan, MD, 352-294-5315, ushnakhan@phhp.edu

    Recruiting

Other trials in United States

About this study

Official title: Rehabilitation-based Approaches to Prevent Mechanical Ventilation-induced Breathing Dysfunction

The goal of this research study is to evaluate the effects of a single session of rehabilitation in healthy adults, before noninvasive mechanical ventilation (MV). MV can help support breathing function during sleep or illness. High levels of MV support have been reported to alter the function of the diaphragm muscle, the primary breathing muscle, in people with compromised health. However, rehabilitation may have some potential to improve diaphragm function in advance of using MV. This study will test different rehabilitation interventions, including (1) inspiratory strength training (IST), (2) transcutaneous spinal cord stimulation (TSCS), or sham TSCS. Before and after MV, participants will complete breathing strength tests and responses to phrenic nerve stimulation.

Read the detailed description

Brief periods of mechanical ventilation (MV) can degrade the function of the diaphragm, which can be a problem for older adults and people with multiple medical comorbidities. 20% of people who are placed on MV require a prolonged effort to wean back to independent breathing. The effects of MV on respiratory neural function are often unaddressed by typical clinical practices. Many aspects of clinical practice such as MV, anesthesia, opioid medication directly reduce respiratory neural drive and degrade diaphragm fiber contractile function, and these impairments can occur rapidly, persist after extubation, and increase the risk for postoperative pulmonary complications. These complications delay discharge, incur significant expenses, and place patients at risk for an incomplete recovery and significant morbidity. Thus, any rehabilitation strategies to preserve or improve phrenic/diaphragm motor function have the potential to expedite early post-operative mobilization and reduce the risk of complications.

Inspiratory muscle strength training (IST) is an effective rehabilitation method to strengthen the diaphragm muscle. Repetitive IST reinforces respiratory neuromuscular plasticity, induces diaphragm remodeling, and improves inspiratory strength. Bouts of high intensity inspiratory loading acutely increase respiratory neural drive and potentiates inspiratory motor recruitment. Additionally, in some clinical situations, IST exercise is not feasible, thus another option may be electrical stimulation of the diaphragm/phrenic motor area (C3-C6) to generate similar improvements in inspiratory drive to preserve breathing function.

The central hypothesis of this proposal is that rehabilitation to increase diaphragm excitability in advance of MV will offset post-MV inspiratory dysfunction. To test this hypothesis, a repeated-measures, blinded study of healthy adults without respiratory comorbidities will be recruited. Consenting participants will complete a familiarization session, followed by three separate, two-hour noninvasive MV sessions, one week apart. MV sessions will be preceded by: 1) a single, high-intensity IST session, and 2) transcutaneous spinal cord stimulation, and 3) sham electrical stimulation, in randomized order. Changes in respiratory drive, voluntary and evoked diaphragm strength, and dyspnea will be evaluated. The central hypothesis will be tested with the following aims:

Aim 1: Test the hypothesis that noninvasive, positive pressure ventilation acutely decreases respiratory drive and maximal diaphragm activation during a two-hour MV session and persists up to 24 hours later.

Aim 2: Test the hypothesis that even single rehabilitation sessions (IST, transcutaneous stimulation) in advance of MV will preserve evoked diaphragm recruitment and hasten early recovery from MV, when compared to sham stimulation.

Being tested
Spinal cord stimulation, Inspiratory Strength Training, Sham Stimulation
Keywords
diaphragm, phrenic nerve, maximal inspiratory pressure, mechanical ventilation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Spinal cord stimulationDevice

    Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes.

  • Inspiratory Strength TrainingBehavioural

    5 sets of 5 breaths of high-intensity inspiratory strength training

  • Sham StimulationOther

    Transcutaneous spinal cord stimulation at reduced intensity, lasting 1 minute at the beginning and end of a 20-minute session.

Study groups in NCT07427121
Study groupRoleWhat they receive
Sham StimulationSham comparatorTranscutaneous spinal cord stimulation at reduced intensity, lasting 1 minute at the beginning and end of a 20-minute session.
Receives: Other: Sham Stimulation
Spinal cord stimulationActive comparatorTranscutaneous spinal cord stimulation at 2mA intensity, for 20 minutes.
Receives: Device: Spinal cord stimulation
Inspiratory strength trainingExperimental5 sets of 5 breaths of high-intensity inspiratory strength training
Receives: Behavioral: Inspiratory Strength Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximal inspiratory pressure

    The most negative pressure generated during a maximal inspiratory effort.

    Measured: T1: baseline strength, T2: 2 hours after MV, T3: 24 hours after MV

  2. Phrenic CMAP Response

    EMG response to supra maximal and bilateral phrenic stimulation

    Measured: up to 24 hours

Secondary outcomes (1)
  1. Diaphragm thickness and excursion

    Diaphragm thickness and excursion will be computed during resting breathing and during inspiratory efforts.

    Measured: up to 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Feb 2026
  2. Study start30 Mar 2026
  3. Primary completion31 Mar 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07427121
Sponsor's protocol ID
IRB202501849
Acronym
REHAB-MV
Status last verified
Apr 2026
First submitted
17 Feb 2026
Last updated
5 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: Participant data that underlie the results reported in this article after deidentification.

Publications

  • Ando R, Ohya T, Kusanagi K, Koizumi J, Ohnuma H, Katayama K, Suzuki Y. Effect of inspiratory resistive training on diaphragm shear modulus and accessory inspiratory muscle activation. Appl Physiol Nutr Metab. 2020 Aug;45(8):851-856. doi: 10.1139/apnm-2019-0906. Epub 2020 Feb 12.

    PubMed 32049562
  • Laghi F, Shaikh H, Littleton SW, Morales D, Jubran A, Tobin MJ. Inhibition of central activation of the diaphragm: a mechanism of weaning failure. J Appl Physiol (1985). 2020 Aug 1;129(2):366-376. doi: 10.1152/japplphysiol.00856.2019. Epub 2020 Jul 16.

    PubMed 32673161
  • Nierat MC, Similowski T, Lamy JC. Does trans-spinal direct current stimulation alter phrenic motoneurons and respiratory neuromechanical outputs in humans? A double-blind, sham-controlled, randomized, crossover study. J Neurosci. 2014 Oct 22;34(43):14420-9. doi: 10.1523/JNEUROSCI.1288-14.2014.

    PubMed 25339753
  • Locher C, Raux M, Fiamma MN, Morelot-Panzini C, Zelter M, Derenne JP, Similowski T, Straus C. Inspiratory resistances facilitate the diaphragm response to transcranial stimulation in humans. BMC Physiol. 2006 Jul 29;6:7. doi: 10.1186/1472-6793-6-7.

    PubMed 16875504
  • Hawkes EZ, Nowicky AV, McConnell AK. Diaphragm and intercostal surface EMG and muscle performance after acute inspiratory muscle loading. Respir Physiol Neurobiol. 2007 Mar 15;155(3):213-9. doi: 10.1016/j.resp.2006.06.002. Epub 2006 Jul 18.

    PubMed 16846758
  • Fauroux B, Isabey D, Desmarais G, Brochard L, Harf A, Lofaso F. Nonchemical influence of inspiratory pressure support on inspiratory activity in humans. J Appl Physiol (1985). 1998 Dec;85(6):2169-75. doi: 10.1152/jappl.1998.85.6.2169.

    PubMed 9843540
  • Bresciani G, Beaver T, Martin AD, van der Pijl R, Mankowski R, Leeuwenburgh C, Ottenheijm CAC, Martin T, Arnaoutakis G, Ahmed S, Mariani VM, Xue W, Smith BK, Ferreira LF. Intraoperative phrenic nerve stimulation to prevent diaphragm fiber weakness during thoracic surgery. PLoS One. 2025 Apr 1;20(4):e0320936. doi: 10.1371/journal.pone.0320936. eCollection 2025.

    PubMed 40168300

Questions about this trial

What is this clinical trial studying?

A study testing Spinal cord stimulation and Inspiratory Strength Training in people with Inspiratory Strength Training (IST) and Transcutaneous Spinal Stimulation, run by University of Florida at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Barbara K Smith, PhD, PT (352-294-5315, bksmith@ufl.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximal inspiratory pressure (time frame: T1: baseline strength, T2: 2 hours after MV, T3: 24 hours after MV). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07427121, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in